Koyfin Home > Directory > Health Care > Intellia Thera CS > Return on Capital %

Intellia Thera CS Return on Capital % Chart (NTLA)

Intellia Thera CS annual/quarterly Return on Capital % from 2015 to 2020.
  • Intellia Thera CS Return on Capital % for the quarter ending June 06, 2020 was -25.53 a 16.20% decrease of -4.14 year over year
  • Intellia Thera CS Return on Capital % for the last 12 months ending June 06, 2020 was -22.56 a 3.46% decrease of -0.78 year over year
  • Intellia Thera CS Annual Return on Capital % for 2019 was -23.48 a 16.39% decrease of -3.85 from 2018
  • Intellia Thera CS Annual Return on Capital % for 2018 was -19.63 a 13.25% decrease of -2.60 from 2017
  • Intellia Thera CS Annual Return on Capital % for 2017 was -17.03 a 14.86% decrease of -2.53 from 2016
Other Margins & Efficiency Metrics:
  • Intellia Thera CS EBITDA Margin for the quarter ending December 12, 2018 was $-249m a 17.09% decrease of -42m year over year
  • Intellia Thera CS Return on Equity % for the quarter ending September 09, 2018 was -33.47 a -20.21% increase of 6.77 year over year
View Chart On Koyfin

Quarterly NTLA Return on Capital % Data

06/2020-25.53
03/2020-29.49
12/2019-25.51
09/2019-21.40
06/2019-23.66
03/2019-21.19
12/2018-19.17
09/2018-22.21
06/2018-20.52
03/2018-18.81

Annual NTLA Return on Capital % Data

2019-23.48
2018-19.63
2017-17.03
2016-14.50
2015-22.37